Ovid Therapeutics Inc.
OVIDBiotechnology
$2.54−0.78%As of Oct 30vs prior close
- Market cap
- $496.1M
- From 52W high
- −14.19%
- EPS (YE23)
- -$0.74
- Revenue (LTM)
- $1.6M
- Net margin
- -2178.90%
- Dividend yield
- 0.00%
Nomior Score
45
Steady ProfileSpeculativeBottom 38% of the scored universe
Growth35
Quality45
Value42
Momentum85
Resilience33
Growth
−10.48%revenue a year over 5 fiscal years
YE20 $12.6MLTM $1.6M
Connections
Revenue to profitQ2 YE26
The operating loss was 2142% of revenue, wider by 2061 pts on a year.
Who owns it
2funds